Although increasing data indicate a role for vitamin D in prostate can
cer, little is known about the role of this hormone in the noncancerou
s prostate. We examined the effect of 1,25-dihydroxyvitamin D-3 (1,25
D) on the growth of noncancerous rat prostates in vivo, Rats were cast
rated and treated with vehicle (controls), 1,25 D, testosterone, or a
combination of both hormones for 2 weeks. Histological examination of
the harvested prostates revealed that 1,25 D had a selective regressiv
e effect on epithelial cells in treated rats compared to untreated cas
trated rats and to normal uncastrated rats. However, 1,25 D stimulated
stromal growth in the prostate. The mean prostatic weight of the vita
min D-treated rats was twice that of the untreated rats (0.13 +/- SEM
0.005 g versus 0.06 +/- SEM 0.006 g). The histological differences wer
e less marked in the testosterone-supplemented animals. A greater degr
ee of cellular differentiation was observed in the rats treated with t
estosterone and vitamin D compared to rats that received testosterone
supplementation alone. Studies of the nuclear matrix composition revea
led differences between the testosterone-supplemented and the testoste
rone and 1,25 D-treated rat prostates. We conclude that in the absence
of testosterone, 1,25 D may exert a growth-promoting effect on the pr
ostatic stroma in vivo. In concert with testosterone, it may play an i
mportant role in the growth and differentiation of the normal rat pros
tate.